Oklahoma SB1427 mandates pediatric screenings for type 1 diabetes at ages 5 and 12, with reimbursement and funding provisions.

Oklahoma SB1427 requires every child in the state to undergo screenings for type 1 diabetes during routine visits at ages 5 and 12. These screenings must be administered by primary health care providers in accordance with accepted medical practices and rules set by the State Commissioner of Health. The bill also mandates the Oklahoma Health Care Authority Board to create necessary rules for implementation and directs the State Department of Health to seek funding. The act will become effective on November 1, 2026.

Oklahoma SB1427 mandates pediatric screenings for type 1 diabetes at ages 5 and 12, with reimbursement and funding provisions.

Oklahoma SB1427 requires every child in the state to undergo screenings for type 1 diabetes during routine visits at ages 5 and 12. These screenings must be administered by primary health care providers in accordance with accepted medical practices and rules set by the State Commissioner of Health. The bill also mandates the Oklahoma Health Care Authority Board to create necessary rules for implementation and directs the State Department of Health to seek funding. The act will become effective on November 1, 2026.